Results 11 to 20 of about 638,748 (156)
Prevalence and determinants of medications non-adherence among patients with uncontrolled hypertension in primary care setting in Sarawak, Malaysia: A cross-sectional study [PDF]
Introduction: Non-adherence to antihypertensive medications is a leading cause of uncontrolled hypertension and its complications. However, data on the factors associated with non-adherence to antihypertensive medications in the communities of Sarawak ...
Hui Zhu Thew +9 more
doaj +1 more source
Factors influencing treatment adherence in paracoccidioidomycosis in Brazil
Introduction Paracoccidioidomycosis is a systemic mycosis endemic to Latin America, with frequent reports of poor treatment adherence resulting in worse clinical outcomes.
Wdson Luis Lima Kruschewsky +7 more
doaj +1 more source
According to the Center for Disease Control, there were more than 107,000 US drug overdose deaths in 2021, over 80,000 of which due to opioids. One of the more vulnerable populations is US military veterans.
Stuart Farquharson +4 more
doaj +1 more source
Objectives Using a multi‐ethnic Asian population, this study assessed adherence to prescribed home exercise programs, explored factors predicting adherence, and evaluated whether home exercise adherence was associated with physical activity.
Bernadine Teng +4 more
doaj +1 more source
The research was distributed by drug services granting conditions up to this moment there are still many problems. As for the problem of the research is "whether the compliance of nurses in identifying influence on accuracy in the service of dispensing".
Agusta Dian Ellina +2 more
doaj +1 more source
Patient Compliance in Systemic Hypertension and to Identify Causes of Non-Compliance
Objective: To assess patient compliance in systemic hypertension and to identify the causes of non-compliance. Study Design: A descriptive observational study.
Muhammad Ali, Jawad Hameed, Muhammad Hamza Zia, Raja Adil Masood, Aamir Shahzad
doaj
Regulatory landscape with U.S. patient requirements and Clinical Trial Diversity expectations
The Food and Drug Administration (FDA) has an expectation that products filed for marketing authorization have to include data that are representative of the US patient population.
Elizabeth George +6 more
doaj +1 more source
ADHERENCE TO MANAGEMENT IN PATIENTS WITH END STAGE RENAL DISEASE
Objective: To document overall adherence to haemodialysis, medications, fluid restriction and dietary prescription in patients with end-stage renal disease and to study factors that could predict poor adherence.
Sheharyar Raashid +2 more
doaj +1 more source
RETRACTED: Patient Compliance: Fact or Fiction?
This article has been retracted: please see INNOVATIONS in pharmacy retraction policy (https://pubs.lib.umn.edu/index.php/innovations/policies). This article has been retracted by the Editor and Publisher due to the inappropriate use of previously ...
AK Mohiuddin
doaj +1 more source

